US20010047200A1 - Non-foreshortening intraluminal prosthesis - Google Patents

Non-foreshortening intraluminal prosthesis Download PDF

Info

Publication number
US20010047200A1
US20010047200A1 US09/416,994 US41699499A US2001047200A1 US 20010047200 A1 US20010047200 A1 US 20010047200A1 US 41699499 A US41699499 A US 41699499A US 2001047200 A1 US2001047200 A1 US 2001047200A1
Authority
US
United States
Prior art keywords
stent
plurality
struts
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/416,994
Inventor
Geoffrey White
Russell Redmond
Alan Plyley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia AB
RAYMOND SUN
Endosystems LLC
Original Assignee
Pharmacia AB
Endosystems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB, Endosystems LLC filed Critical Pharmacia AB
Priority to US09/416,994 priority Critical patent/US20010047200A1/en
Assigned to PHARMACIA & UPJOHN AB reassignment PHARMACIA & UPJOHN AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NORRBY, SVERKER, HUO, PETER P., LIAU, CHRISTINE J.Y., ZHOU, STEPHEN Q.
Assigned to ENDOSYSTEMS LLC reassignment ENDOSYSTEMS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PLYLEY, ALAN K., REDMOND, RUSSELL J., WHITE, GEOFFREY H.
Publication of US20010047200A1 publication Critical patent/US20010047200A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped

Abstract

A stent has a plurality of cells disposed about the circumference of the stent, with at least one cell having a plurality of struts that are connected together to form the cell. At least one strut has a portion that compensates for foreshortening of the struts during expansion of the stent.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The present invention relates to intraluminal prostheses for implantation into a mammalian vessel, and in particular, to intraluminal stents that do not experience foreshortening in the longitudinal direction when the stent is deployed to an expanded state. [0002]
  • 2. Description of the Prior Art [0003]
  • Intraluminal prosthesis, such as stents, are commonly used in the repair of aneurysms, as liners for vessels, or to provide mechanical support to prevent the collapse of stenosed or occluded vessels. These stents are typically delivered in a compressed state to a specific location inside the lumen of a vessel or other tubular structures, and then deployed at that location of the lumen to an expanded state. These stents have a diameter in their expanded state which is several times larger than the diameter of the stents in the compressed state. These stents are also frequently deployed in the treatment of atherosclerotic stenosis in blood vessels, especially after percutaneous transluminal coronary angioplasty (PTCA) procedures, to improve the results of the procedure and to reduce the likelihood of restenosis. [0004]
  • U.S. Pat. Nos. 5,733,303 (Israel et al.) and 5,827,321 (Roubin et al.) describe the problems associated with the foreshortening of intraluminal stents when such stents are expanded. In addition, U.S. Pat. No. 5,733,303 (Israel et al.) describes stents that have struts whose longitudinal length decreases when the stent expands, thereby causing the overall longitudinal length of the stent to foreshorten. These struts are connected by flexible connecting members, each having an area of inflection that functions to compensate for the foreshortening experienced by the struts during expansion of the stent. [0005]
  • Unfortunately, there are certain drawbacks associated with providing flexible connecting members that have areas of inflection. First, to accommodate the areas of inflection, these connecting members often create segments within the stent where the aperture or opening defined by these connecting members have a large size. Such increased aperture size may allow increased ingrowth of tissue (also known as “in-stent restenosis”). Second, curved areas of inflection on these connecting members may cause distortion of the lumen of the stent when the stent is twisted or experiences angulation in the longitudinal direction. Third, the connecting members form an area of weakness in the stent structure which may encourage kink of the stent at the site with flexion or angulation, or which in extreme circumstances may lead to stent breakage after experiencing repetitive stress. In other words, the provision of the connecting members decreases the amount of support that the stent can enjoy. [0006]
  • Thus, there still remains a need for an intraluminal prosthesis that maintains a consistent length in both its fully compressed and fully expanded states, while avoiding the disadvantages set forth above. There also remains a need for a stent which can accommodate body vessels having varying lumen diameters, different anatomies, and different disease states. [0007]
  • SUMMARY OF THE DISCLOSURE
  • It is an object of the present invention to provide an intraluminal prosthesis that maintains a consistent length in both its fully compressed and fully expanded states. [0008]
  • It is another object of the present invention to provide an intraluminal prosthesis that provides increased support throughout the prosthesis while minimizing the potential for stent kink or breakage at certain regions along the stent. [0009]
  • It is yet another object of the present invention to provide an intraluminal prosthesis that minimizes the potential for in-stent restenosis. [0010]
  • In order to accomplish the objects of the present invention, there is provided a stent having a plurality of cells disposed about the circumference of the stent, with at least one cell having a plurality of struts that are connected together to form the cell. At least one strut has a portion that compensates for foreshortening of the struts during expansion of the stent. [0011]
  • In another embodiment, the present invention provides a stent having a plurality of cells disposed about the circumference of the stent, with at least one cell having a plurality of double-struts that are connected together to form the cell. [0012]
  • Thus, the stent according to the present invention maintains a consistent length in both its fully compressed and fully expanded states, and in all states between its fully compressed and fully expanded states. As a result, the stent according to the present invention facilitates accurate sizing and deployment, thereby simplifying, and possibly reducing the time needed for, the medical procedure.[0013]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a stent according to one embodiment of the present invention; [0014]
  • FIG. 2A is a side elevational view of a portion of the stent of FIG. 1 in its expanded state; [0015]
  • FIG. 2B is a side elevational view of the portion of FIG. 2A in its compressed state; [0016]
  • FIG. 3A is an enlarged side elevational view of a cell of the portion of FIG. 2A; [0017]
  • FIG. 3B illustrates the longitudinal component of a strut and its compensating portion of FIG. 3A when the stent is in its expanded state; [0018]
  • FIG. 3C illustrates the longitudinal component of a strut and its compensating portion of FIG. 3A when the stent is in its compressed state; [0019]
  • FIG. 4 illustrates a modification to the cell pattern of the stent of FIGS. 1 and 2A; [0020]
  • FIG. 5 is an enlarged side elevational view of a cell of portion of a stent according to another embodiment of the present invention; [0021]
  • FIG. 6A is a side elevational view of a portion of a stent according to another embodiment of the present invention; [0022]
  • FIG. 6B is a side elevational view of the portion of FIG. 6A in its compressed state; [0023]
  • FIG. 6C illustrates the longitudinal component of a strut and its compensating portion of FIG. 6A when the stent is in its expanded state; [0024]
  • FIG. 6D illustrates the longitudinal component of a strut and its compensating portion of FIG. 6A when the stent is in its compressed state; [0025]
  • FIGS. [0026] 7-9 are side elevational views of portions of stents according to other embodiments of the present invention;
  • FIG. 10 is an enlarged side elevational view of a cell of portion of a stent according to another embodiment of the present invention; [0027]
  • FIGS. [0028] 11-14 are side elevational views of portions of stents according to other embodiments of the present invention; and
  • FIG. 15A is a side elevational view of a portions of a stent according to another embodiments of the present invention; [0029]
  • FIG. 15B is a side elevational view of the portion of FIG. 15A in its compressed state; and [0030]
  • FIGS. [0031] 16-18 illustrate modifications to the cell pattern of the stent of FIG. 15.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The following detailed description is of the best presently contemplated modes of carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating general principles of embodiments of the invention. The scope of the invention is best defined by the appended claims. [0032]
  • The intraluminal prosthesis according to the present invention is a stent, although the principles of the present invention are also applicable to other prosthesis such as liners and filters. The stent is delivered to a desired location in the lumen of a body vessel in a compressed state, and is then deployed by expanding it to its expanded state. The stent maintains substantially the same length in both its fully compressed and fully expanded states. [0033]
  • The stent according to the present invention can be a self-expanding stent, or a stent that is radially expandable by inflating a balloon or expanded by an expansion member, or a stent that is expanded by the use of radio frequency which provides heat to cause the stent to change its size. The stent may also be coated with coverings of PTFE, dacron, or other biocompatible materials to form a combined stent-graft or endovascular prosthesis. The vessels in which the stent of the present invention can be deployed include but are not limited to natural body vessels such as ducts, arteries, trachea, veins, ureters and the esophagus, and artificial vessels such as grafts. [0034]
  • A stent [0035] 20 according to the present invention is illustrated in FIGS. 1, 2A and 3A in its expanded state. Referring to FIG. 1, the stent 20 has a tubular configuration and is made up of a plurality of cells that are comprised of generally V-shaped struts connected at their apices. FIGS. 2A and 2B illustrate a portion of the stent 20 in greater detail, and FIG. 3A illustrates one cell 22. Each cell 22 has a first strut 24 having a first end 26 and a second end 28, a second strut 30 having a first end 32 and a second end 34, a third strut 36 having a first end 38 and a second end 40, and a fourth strut 42 having a first end 44 and a second end 46. The first ends 26 and 32 of the first and second struts 24 and 30, respectively, are connected at a first apex 48, and the first ends 38 and 44 of the third and fourth struts 36 and 42, respectively, are connected at a second apex 50. The second ends 28 and 40 of the first and third struts 24 and 36, respectively, are connected to form a third apex 52, and the second ends 34 and 46 of the second and fourth struts 30 and 42, respectively, are connected to form a fourth apex 54, so that the four struts 24, 30, 36 and 42 together form an aperture or open space 56.
  • As shown in FIG. 2A, the first apex [0036] 48 of each cell 22 is connected to the second apex 50 of a longitudinally adjacent cell 22, and the third apex 52 of each cell 22 is connected to the fourth apex 54 of a transversely adjacent cell 22. For purposes of the present invention, cells 22 can be provided in longitudinal rows and transverse columns. Therefore, the first and second apices 48 and 50 of adjacent cells 22 are connected to form a row R of cells 22, while the third and fourth apices 52 and 54 of adjacent cells 22 are connected to form a column C of cells 22.
  • The struts [0037] 24, 30, 36 and 42 would normally experience foreshortening when the stent 20 is expanded. Therefore, any of the struts 24, 30, 36 and 42 can be provided with a compensating portion 60 that functions to compensate for the foreshortening experienced by the struts 24, 30, 36 and 42 during expansion of the stent 20. As shown in greater detail in FIG. 3A, each compensating portion 60 has at least one point of inflection. In the non-limiting example shown in FIG. 3A, the compensating portion 60 has three points of inflection 62 and 64 that are inflected in directions opposite to each other. One point of inflection 62 can be considered to be an external point of inflection since it extends outside the confines of the cell 22 as defined by the struts 24, 30, 36 and 42. Similarly, each of the other two points of inflection 64 can be considered to be an internal point of inflection since it extends into the aperture 56. Each compensating portion 60 can be provided along any portion of the strut 36 and 42, and slopes downwardly from one end of the strut 36 and 42 to an internal point of inflection 64, at which point it slopes upwardly to the external point of inflection 62, then slopes downwardly to the other internal point of inflection 64, before sloping upwardly again towards the other end of the strut 36 or 42. Thus, each compensating portion 60 has a plurality of alternating segments that are defined by the points of inflection 62 and 64.
  • As best shown in FIG. 2A, the pattern of cells [0038] 22 can define a second pattern of cells 22 x that have about the same configuration as the cells 22, but reversed about a vertical axis defined by apices 52 and 54 to form a substantial mirror image of the cells 22. Each of the second cells 22 x is defined by a separate strut from four separate cells 22. Like the cells 22, these second cells 22 x are also arranged to form rows and columns of cells 22 x.
  • Referring to FIG. 2B, when the stent [0039] 20 is in the compressed state, the internal points of inflection 64 are adjacent to each other. However, it is possible to position the compensating portions 60 along the third and fourth struts 36 and 42 so that the points of inflection 62, 64 can be nested within each other when the stent 20 is compressed. In such a case, when the stent 20 is compressed, an internal point of inflection 64 of the third strut 36 can be nested or fitted inside the space defined by an external point of inflection 62 of the fourth strut 42, and an internal point of inflection 64 of the fourth strut 42 can nested or fitted inside the space defined by an external point of inflection 62 of the third strut 36.
  • As another example, it is possible to also provide the compensating portions [0040] 60 for the first and second struts 24 and 30, in addition to or in lieu of the compensating portions 60 for the third and fourth struts 36 and 42. For example, FIG. 10 illustrates a cell 22 where each strut 24, 30, 36 and 42 has a compensating portion 60.
  • The compensating portions [0041] 60 function to compensate for the longitudinal foreshortening experienced by the struts 24, 30, 36, 42, thereby maintaining the stent 20 at substantially the same length at all times. This is accomplished by providing the compensating portions 60 with a natural bias and a springy nature, which together with its alternating segments, combine to shorten its length l1 (see FIG. 3B) when compressed (i.e., 1 2 in FIG. 3C is less than l1). When allowed to expand, each compensating portion 60 is biased to return to its natural or original position, which increases its length from l2 to l1 to compensate for the foreshortening experienced by the longitudinal component of each strut 24, 30, 36, 42.
  • This effect is illustrated in FIGS. 2A, 2B, [0042] 3A, 3B and 3C. When the stent 20 is in its compressed state, the compensating portion 60 has an actual length which is less than its actual length when the compensating portion 60 is in its expanded state. When the compensating portion 60 is in the compressed state, its alternating segments have a higher amplitude and a smaller wavelength than when it is in the expanded state (compare FIGS. 3B and 3C). Thus, this difference between the actual lengths of the compensating portion 60 in its two compressed and expanded states compensates for the difference between l1 and l2 of the struts 36 and 42, so that the longitudinal lengths L1 and L2 of the strut (e.g., 36) are the same in both the compressed and expanded states. The lines 70 and 72 in FIGS. 2A and 2B also show that the relevant portion of the stent 20 does not experience any foreshortening.
  • FIG. 4 illustrates a modification to the cell pattern for stent [0043] 20 shown in FIG. 2A. In particular, the cell pattern 20 a in FIG. 4 provides a plurality of straight connecting members 80 that connect the first and second apices 48 and 50, respectively, of adjacent cells 22 in a longitudinal row R. These straight connecting members 80 can increase the flexibility of the stent, primarily in the longitudinal direction, but also to a small degree in the radial direction. In addition, one or more of these straight connecting members 80 can be omitted, either randomly or in a pattern (e.g., in a spiral pattern) to increase the flexibility of the stent at desired locations.
  • Although the compensating portions [0044] 60 have been described in FIGS. 1-3 as assuming a particular configuration, it will be appreciated by those skilled in the art that the compensating portions 60 can assume other configurations without departing from the spirit and scope of the present invention. For example, the compensating portion 60 can be modified so that each has two points of inflection. This is illustrated in FIG. 5, where the third strut 36 has a compensating portion 60 a that has one external point of inflection 62 a and one internal point of inflection 64 a, and the fourth strut 42 has a compensating portion 60 a that has one external point of inflection 62 a and one internal point of inflection 64 a.
  • FIGS. [0045] 6-9 illustrate another type of compensating portion 90 according to the present invention which is configured to be a generally incomplete or C-shaped circle provided at one or more apices of the cells. For example, referring to FIG. 6A, each cell 22 b is essentially the same as cell 22 in FIG. 3A, except that the compensating portions 60 have been replaced by compensating portions 90 b that are provided at the location of the first and second apices 48 and 50 in such a manner that the first and second apices 48 and 50 are replaced by these compensating portions 90 b. Each compensating portion 90 b has a generally incomplete circular or C-shaped configuration, extending from the first end 26 b, 32 b, 38 b or 44 b of one of the struts 24 b, 32 b, 36 b or 42 b, respectively, then curling around in a circular fashion to the first end 26 b, 32 b, 38 b or 44 b of the adjacent strut 24 b, 32 b, 36 b or 42 b, respectively. The elements of the cell 22 b that are the same as the elements of the cell 22 in FIG. 3A are provided with the same numeral designations except that a “b” has been added to the numeral designations in FIG. 6A.
  • Each compensating portion [0046] 90 b of each cell 22 b is longitudinally (i.e., along a row) connected to a compensating portion 90 b of an adjacent cell 22 b by a straight connecting member 80 b. The compensating portions 90 b function in the same manner as the compensating portions 60 to compensate for the longitudinal foreshortening experienced by the struts 24 b, 30 b, 36 b, 42 b. In this regard, the generally circular curved configuration of the compensating portions 90 b has one area of inflection 95 so that each compensating portion 90 b has a shortened longitudinal length L2 when compressed, but has an increased longitudinal length L1 when allowed to expand so as to compensate for the foreshortening experienced by the longitudinal component of each strut 24 b, 30 b, 36 b, 42 b. This effect is illustrated in FIGS. 6B, 6C and 6D.
  • FIG. 7 illustrates a stent pattern in which each cell [0047] 22 c is essentially the same as cell 22 b in FIG. 6A, except that the compensating portions 90 c are now provided at the third and fourth apices 52 and 54, respectively, in such a manner that the third and fourth apices 52 and 54 are replaced by these compensating portions 90 c. Each compensating portion 90 c has the same configuration as compensating portion 90 b. The elements of the cell 22 c that are the same as the elements of the cell 22 b in FIG. 6A are provided with the same numeral designations except that a “c” has been added to the numeral designations in FIG. 7. Each compensating portion 90 c of each cell 22 c can be transversely (i.e., along a column) connected to a compensating portion 90 c of an adjacent cell 22 c by a straight connecting member 80 c.
  • The principles illustrated in FIGS. 6A and 7 can be combined. For example, FIG. 8 illustrates a stent pattern in which each cell [0048] 22 d has compensating portions 90 d provided at all four apieces 48, 50, 52 and 54, in such a manner that each of the four apieces 48, 50, 52 and 54 is replaced by a compensating portion 90 d. Each compensating portion 90 d of each cell 22 d can be either longitudinally or transversely connected to a compensating portion 90 d of an adjacent cell 22 d by a straight connecting member 80 d. The elements of the cell 22 d that are the same as the elements of the cells 22 b and 22 c are provided with the same numeral designations except that a “d” has been added to the numeral designations in FIG. 8.
  • In addition, FIG. 9 illustrates a stent pattern which is the same as the stent pattern in FIG. 8, except that the connecting members [0049] 80 d are omitted. Thus, each compensating portion 90 e of each cell 22 e in FIG. 9 is directly connected, either longitudinally or transversely, to a compensating portion 90 e of an adjacent cell 22 e. The elements of the cell 22 e that are the same as the elements of the cell 22 d are provided with the same numeral designations except that an “e” has been added to the numeral designations in FIG. 9.
  • FIGS. 11 and 12 illustrate different types of compensating portions according to the present invention that embody the underlying principles described in connection with FIGS. [0050] 6-9. In FIG. 11, each cell 22 g shares a compensating portion 90 g with each longitudinally adjacent cell 22 g. In particular, each compensating portion 90 g is shaped like a sideway “S”, with the top of the “S” coupled to a first cell 22 g at the location of (and replacing) the first apex 48, and with the bottom of the “S” coupled to a longitudinally adjacent second cell 22 g at the location of (and replacing) the second apex 50 of the second cell 22 g. Thus, the sideway “S” shape of each compensating portion 90 g defines two areas of inflection 100 and 102 that function to provide the compensation needed to avoid foreshortening according to the principles set forth in FIGS. 2-9 above. Otherwise, the elements of the cell 22 g in FIG. 11 that are the same as the elements of the cell 22 in FIG. 3A are provided with the same numeral designations except that a “g” has been added to the numeral designations in FIG. 11.
  • Similarly, in FIG. 12, each cell [0051] 22 h shares a compensating portion 90 h with each longitudinally adjacent cell 22 h. In particular, each compensating portion 90 h is configured like the compensating portion 90 b in FIG. 6, except that a first end 106 of the compensating portion 90 h is connected to the first end 44 h of the fourth strut 42 h of a first cell 22 h, with the compensating portion 90 h curling around in a circular fashion to its second end 108, which is connected to the first end 32 h of the second strut 30 h of a longitudinally adjacent second cell 22 h. The first end 38 h of the third strut 36 h of the first cell 22 h is connected to the compensating portion 90 h between the first and second ends 106 and 108 thereof, and the first end 26 h of the first strut 24 h of the second cell 22 h is connected to the compensating portion 90 h between the second end 108 and the first end 38 h of the third strut 36 h of the first cell 22 h. Thus, the compensating portion 90 h defines one area of inflection 110 between two longitudinally adjacent cells 22 h that functions to provide the compensation needed to avoid foreshortening according to the principles set forth in FIGS. 2-9 above. Otherwise, the elements of the cell 22 h in FIG. 12 that are the same as the elements of the cell 22 in FIG. 3A are provided with the same numeral designations except that an “h” has been added to the numeral designations in FIG. 12.
  • It is not necessary that the struts [0052] 24, 30, 36, 42 be straight. In this regard, the present invention provides cells having curved struts that provide at least one area of inflection to provide the compensation needed to avoid foreshortening according to the principles set forth in FIGS. 2-10 above. As a non-limiting example, FIG. 13 illustrates a stent pattern in which the cells 22 i are essentially the same as the cell 22 in FIG. 3A, except that each strut 24 i, 30 i, 36 i and 42 i is now completely curved. Otherwise, the elements of the cell 22 i in FIG. 13 that are the same as the elements of the cell 22 in FIG. 3A are provided with the same numeral designations except that an “i” has been added to the numeral designations in FIG. 13.
  • The cells [0053] 22 j in the stent pattern in FIG. 14 borrow from the principles illustrated in FIGS. 3A and 13. Each strut in the cells 22 j are made up of two strut pieces that have their respective ends connected at the apices 48 j, 50 j, 52 j and 54 j. In particular, the first strut 24 j has an accompanying inner strut piece 24 k whose ends are also connected to the apices 48 j and 52 j, the second strut 30 j has an accompanying inner strut piece 30 k whose ends are also connected to the apices 48 j and 54 j, the third strut 36 j has an accompanying inner strut piece 36 k whose ends are also connected to the apices 50 j and 52 j, and the fourth strut 42 j has an accompanying inner strut piece 42 k whose ends are also connected to the apices 50 j and 54 j. Each strut 24 j, 30 j, 36 j, 42 j and its accompanying inner strut piece 24 k, 30 k, 36 k, 42 k defines a smaller cell 120, 122, 124, 126, respectively. In this embodiment, the inner strut pieces 24 k, 30 k, 36 k, 42 k are shorter than each corresponding strut 24 j, 30 j, 36 j, 42 j.
  • Providing double struts to make up the desired cells [0054] 22 j can provide certain benefits. First, the double-strut structure may increase the strength of the stent by providing radial and longitudinal resistance to compression and other changes in shape. Second, the resulting stent may have an increased expansion ratio. Third, the double-strut structure may reduce the tendency of the stent to recoil. Fourth, the resulting stent may have increased stent coverage and cells that have smaller sizes, thereby minimizing tissue in-growth. The double-strut embodiment of FIG. 14 can be especially useful in applications where the prosthesis requires increased support throughout the prosthesis while minimizing the potential for stent kink or breakage at certain regions along the stent.
  • FIG. 15A illustrates a stent [0055] 20 m in which the cells 22 m are essentially the same as the cell 22 i in FIG. 13, except that each strut 24 m, 30 m, 36 m and 42 m has less curvature. In fact, each strut 24 m, 30 m, 36 m and 42 m has one internal point of inflection 64 m and one external point of inflection 62 m. Otherwise, the elements of the cell 22 m in FIG. 15 that are the same as the elements of the cell 22 i in FIG. 13 are provided with the same numeral designations except that an “m” has been added to the numeral designations in FIG. 15. Similar to FIG. 2A, the pattern of cells 22 m can define a second pattern of cells 22 y that have about the same configuration as the cells 22 m, but reversed about a horizontal axis defined by the apices 48 m and 50 m. Like the cells 22 m, these second cells 22 y are also arranged to form rows and columns of cells 22 y. Each of the second cells 22 y is defined by a separate strut from four separate cells 22 m. FIG. 15B illustrates the stent 20 m in the compressed state. One difference between the cell 22 m and the other cells 22 herein is that the apex 54 m in each cell 22 m is inverted internally into the cell 22 m, as opposed to extending externally from the cell 22 m.
  • While the embodiments illustrated hereinabove illustrate stent patterns that are made up entirely of cells [0056] 22 that have compensating portions 60, it is also possible to intersperse cells that do not have any compensating portions 60. These principles will be illustrated in FIGS. 16-18 using the cell pattern 22 m of FIG. 15. Referring first to FIG. 16, a stent 20 m is illustrated as having a central portion 150 made up of a plurality of conventional zig-zag struts that do not have any compensating portions, and which form diamond-shaped cells 152. The two ends of the stent 20 m is made up of the cell pattern 22 m illustrated in FIG. 15. This configuration provides more rigidity in the central portion 150, and is better suited for use, for example, in the carotid arteries where more calcified lesions can be found at about the central portion 150, and where there is more potential for embolization in the central portion 150. This is because the diamond-shaped cells 152 are better suited to minimize embolization and prevent tissue in-growth.
  • FIG. 17 illustrates a stent [0057] 20 n having a first portion 154 made up of a plurality of conventional zig-zag struts that do not have any compensating portions, and which form diamond-shaped cells 152, and a second portion 156 that is made up of the cell pattern 22 m illustrated in FIG. 15. The first portion 154 can be used to support a body vessel at a location that requires more rigidity, and the second portion 156 can be used to support a body vessel at a location that requires more flexibility. This configuration is better suited for use, for example, in the iliac arteries where the origin of the iliac arteries might have more calcified lesions where the first portion 154 would be intended to support.
  • FIG. 18 illustrates a stent [0058] 20 p having rows 158 of cells 22 m separated by one or more rows of the diamond-shaped cells 152. The rows 158 can be individual rows of cells 22 m, or a plurality of rows of cells 22 m. This configuration is useful in distributing the radial strength of the stent 20 p while allowing for nonforeshortening and increased flexion at the desired locations (i.e., supported by the cells 22 m). This configuration is best suited for use, for example, with curved vessels such as external iliac arteries.
  • A number of materials can be used to fabricate the stent [0059] 20 (including its struts 24, 30, 36, 42 and connecting members 80), depending on its method of deployment. These materials include, but are not limited to, Nitinol (which is a shape memory superelastic metal alloy whose use in stents is well-documented in the literature), stainless steel, tantalum, titanium, elgiloy, gold, platinum, or any other metal or alloy, or polymers or composites, having sufficient biocompatibility, rigidity, flexibility, radial strength, radiopacity and antithrombogenicity.
  • The stent [0060] 20 can be made from one of a number of methods, depending on the material of the stent 20 and the desired nature of deployment.
  • In a non-limiting first preferred method, the stent [0061] 20 is fabricated from a solid Nitinol tube with dimensions that are identical to the stent 20 when it is in the fully compressed state. The pattern of the stent 20 (i.e., its cells 22) is programmed into a computer-guided laser cutter which cuts out the segments between the struts and the connecting members (if any) in a manner which closely maintains the outside diameter and wall thickness of the stent 20.
  • After the cutting step, the stent [0062] 20 is progressively expanded until it reaches its fully expanded state. The expansion can be performed by an internal expansion fixture, although other expansion apparatus and methods can be used without departing from the spirit and scope of the present invention. The overall length of the stent 20 must be consistently maintained throughout the expansion of the stent 20 from its fully compressed to its fully expanded states.
  • Once the stent [0063] 20 has been expanded to its fully expanded state, it is heat-treated to “set” the shape memory of the Nitinol material so that it will fully return to its expanded dimensions at a temperature that is near body temperature. The stent 20 is then cleaned and electro-polished.
  • The next step is to compress the stent [0064] 20 again into a dimension which allows for delivery into a vessel, either through percutaneous delivery or through minimally invasive surgical procedures. Specifically, the stent 20 must be compressed into a smaller state so that it can be delivered by a delivery device to the desired location of the vessel. Any conventional delivery device could be used, such as but not limited to a tube, catheter, or sheath. This compression is accomplished by cooling the stent 20 to a low temperature, for example, zero degrees Celcius, and while maintaining this temperature, compressing the stent 20 to allow the stent 20 to be inserted inside the delivery device. Once inserted inside the delivery device, the stent 20 is held by the delivery device in the compressed state until it is released within the lumen of a vessel, at which time the stent will fully re-expand to its “set” dimensions as it equilibrates with body temperature.
  • In a non-limiting second preferred method, a balloon-expandable stent [0065] 20 can be fabricated by connecting a plurality of wires that have been bent or formed into the desired shapes for the struts 24, 30, 36, 42 and connecting members 80. The connection can be accomplished by welding, tying, bonding, or any other conventional method. Alternatively, wire electro-discharge machining or a computer guided laser cutter can be used. The wires are capable of experiencing plastic deformation when the stent 20 is compressed, and when the stent 20 is expanded. Upon plastic deformation of the stent 20 to either the compressed or the expanded state, the stent 20 remains in this state until another force is applied to plastically deform the stent 20 again.
  • While certain methods of manufacture have been described above, it will be appreciated by those skilled in the art that other methods of manufacture can be utilized without departing from the spirit and scope of the present invention. [0066]
  • The stent [0067] 20 can be deployed by a number of delivery systems and delivery methods. These delivery systems and methods will vary depending on whether the stent 20 is expanded by self-expansion, radial expansion forces, or radio frequency. These delivery methods are well-known in the art, and shall not be described in greater detail herein.
  • Thus, the present invention provides a stent having struts that include portions that compensate for the foreshortening effect. As a result, connecting members can be omitted from the stent designs according to the present invention, leading to at least the following benefits. First, cell sizes can be decreased so as to minimize “in-stent restenosis”, and to provide better support to the vessel. Second, the stent can be provided with a more uniform structure that distributes any angulation or flexion of the stent more evenly along the full length of the stent, so that the stent can experience a more gradual curvature at bends rather than experiencing undesirable kinking at such regions. This further minimizes breakage or other damage to the stent. Of course, connecting members can be optionally added to increase the flexibility of the stent at certain desired areas. [0068]
  • While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention. [0069]

Claims (22)

What is claimed is:
1. A stent comprising:
a plurality of cells disposed about the circumference of the stent, with at least one cell having a plurality of struts that are connected together to form the cell, with at least one strut having a compensating portion that compensates for foreshortening of the struts during expansion of the stent.
2. The stent of
claim 1
, further including a connecting member for coupling two adjacent cells.
3. The stent of
claim 1
, wherein the compensating portion has at least one area of inflection.
4. The stent of
claim 1
, wherein the compensating portion has an internal area of inflection and an external area of inflection.
5. The stent of
claim 1
, wherein each of the struts has a compensating portion.
6. The stent of
claim 1
, wherein each of the plurality of cells has four struts that define a generally diamond-shaped configuration having four apices, with a compensating portion provided at one of the apices.
7. The stent of
claim 6
, wherein a compensating portion is provided at two of the apices.
8. The stent of
claim 6
, wherein a compensating portion is provided at all the apices.
9. The stent of
claim 6
, wherein the compensating portion is C-shaped.
10. The stent of
claim 6
, wherein the compensating portion is connects apices between two adjacent cells.
11. The stent of
claim 10
, wherein the compensating portion is S-shaped.
12. The stent of
claim 10
, wherein the compensating portion is C-shaped.
13. The stent of
claim 1
, wherein each strut is completely curved.
14. The stent of
claim 1
, wherein the plurality of cells is a first plurality of cells that defines a first plurality of rows and columns, and wherein the stent further includes a second plurality of cells that defines a second plurality of rows and columns.
15. The stent of
claim 14
, wherein the configuration of the first plurality of cells is a substantial mirror image of the second plurality of cells.
16. The stent of
claim 1
, wherein the plurality of cells is a first plurality of cells that is provided along a first length of the stent, and wherein the stent further includes a second plurality of cells that-is provided along a second length of the stent.
17. The stent of
claim 1
, wherein the compensating portion is curved.
18. The stent of
claim 1
, wherein each cell has a plurality of apices that are defined by the plurality of struts, and each of the plurality of struts includes a first strut and a second strut to define a double-strut configuration, with each of the first and second struts having a first end and a second end, wherein the first ends of the first and second struts are connected to a first apex, and the second ends of the first and second struts are connected to a second apex.
19. The stent of
claim 18
, wherein the first and second struts of each of the plurality of struts defines a space therebetween.
20. A stent comprising a plurality of cells disposed about the circumference of the stent, with at least one cell having a plurality of double-struts that are connected together to form the cell.
21. The stent of
claim 20
, wherein each cell has a plurality of apices that are defined by the plurality of double-struts, and with each of double-struts having a first end and a second end, wherein the first ends of the double-struts are connected to a first apex, and the second ends of the double-struts are connected to a second apex.
22. The stent of
claim 21
, wherein each double-strut defines a space therebetween.
US09/416,994 1999-10-13 1999-10-13 Non-foreshortening intraluminal prosthesis Abandoned US20010047200A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/416,994 US20010047200A1 (en) 1999-10-13 1999-10-13 Non-foreshortening intraluminal prosthesis

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US09/416,994 US20010047200A1 (en) 1999-10-13 1999-10-13 Non-foreshortening intraluminal prosthesis
JP2001529376A JP2003523792A (en) 1999-10-13 2000-10-12 Non-shortening of the lumen artificial organs
CA002386335A CA2386335C (en) 1999-10-13 2000-10-12 Non-foreshortening intraluminal prothesis
PCT/US2000/028281 WO2001026583A1 (en) 1999-10-13 2000-10-12 Non-foreshortening intraluminal prosthesis
EP00973496A EP1233723A4 (en) 1999-10-13 2000-10-12 Non-foreshortening intraluminal prosthesis
AU11999/01A AU779189B2 (en) 1999-10-13 2000-10-12 Non-foreshortening intraluminal prosthesis
US10/051,433 US6881222B2 (en) 1999-10-13 2002-01-18 Non-foreshortening intraluminal prosthesis
US11/107,088 US8721705B2 (en) 1999-10-13 2005-04-14 Non-foreshortening intraluminal prosthesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/051,433 Division US6881222B2 (en) 1999-10-13 2002-01-18 Non-foreshortening intraluminal prosthesis

Publications (1)

Publication Number Publication Date
US20010047200A1 true US20010047200A1 (en) 2001-11-29

Family

ID=23652164

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/416,994 Abandoned US20010047200A1 (en) 1999-10-13 1999-10-13 Non-foreshortening intraluminal prosthesis
US10/051,433 Expired - Fee Related US6881222B2 (en) 1999-10-13 2002-01-18 Non-foreshortening intraluminal prosthesis
US11/107,088 Expired - Fee Related US8721705B2 (en) 1999-10-13 2005-04-14 Non-foreshortening intraluminal prosthesis

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/051,433 Expired - Fee Related US6881222B2 (en) 1999-10-13 2002-01-18 Non-foreshortening intraluminal prosthesis
US11/107,088 Expired - Fee Related US8721705B2 (en) 1999-10-13 2005-04-14 Non-foreshortening intraluminal prosthesis

Country Status (6)

Country Link
US (3) US20010047200A1 (en)
EP (1) EP1233723A4 (en)
JP (1) JP2003523792A (en)
AU (1) AU779189B2 (en)
CA (1) CA2386335C (en)
WO (1) WO2001026583A1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092549A2 (en) * 2002-05-06 2003-11-13 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
US6679911B2 (en) * 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6820676B2 (en) 1999-11-19 2004-11-23 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US20050182477A1 (en) * 2001-12-20 2005-08-18 White Geoffrey H. Intraluminal stent and graft
US20060122691A1 (en) * 1998-12-03 2006-06-08 Jacob Richter Hybrid stent
US7122049B2 (en) 2003-03-19 2006-10-17 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US20090171426A1 (en) * 2007-12-28 2009-07-02 Cook Incorporated Radially expandable stent
US7625401B2 (en) 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
US7704274B2 (en) 2002-09-26 2010-04-27 Advanced Bio Prothestic Surfaces, Ltd. Implantable graft and methods of making same
US20110009941A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110009950A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110009875A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Embolic obstruction retrieval devices and methods
US20110009940A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US7985249B2 (en) 2002-05-08 2011-07-26 Abbott Laboratories Corporation Endoprosthesis having foot extensions
US20110184456A1 (en) * 2009-07-08 2011-07-28 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8048146B2 (en) 2003-05-06 2011-11-01 Abbott Laboratories Endoprosthesis having foot extensions
US8092514B1 (en) * 1998-11-16 2012-01-10 Boston Scientific Scimed, Inc. Stretchable anti-buckling coiled-sheet stent
US20130131788A1 (en) * 2008-09-29 2013-05-23 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US8529596B2 (en) 2009-07-08 2013-09-10 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8641754B2 (en) * 2000-11-07 2014-02-04 Advanced Bio Prosthetic Surfaces, Ltd. a wholly owned subsidiary of Palmaz Scientific, Inc. Endoluminal stent, self-supporting endoluminal graft and methods of making same
US20140172086A1 (en) * 2009-04-15 2014-06-19 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US20140371839A1 (en) * 2002-07-19 2014-12-18 Covidien Lp Medical implant having a curlable matrix structure and method of use
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9072537B2 (en) 2009-07-08 2015-07-07 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US9433514B2 (en) 2005-11-10 2016-09-06 Edwards Lifesciences Cardiaq Llc Method of securing a prosthesis
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9956320B2 (en) 2003-06-27 2018-05-01 Zuli Holdings Ltd. Amorphous metal alloy medical devices
US10016275B2 (en) 2012-05-30 2018-07-10 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10213298B2 (en) 2004-03-11 2019-02-26 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173531A1 (en) * 1996-09-19 2006-08-03 Jacob Richter Stent with variable features to optimize support and method of making such stent
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US7815763B2 (en) 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US20020019660A1 (en) * 1998-09-05 2002-02-14 Marc Gianotti Methods and apparatus for a curved stent
US6682554B2 (en) * 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US8070792B2 (en) 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US20010047200A1 (en) * 1999-10-13 2001-11-29 Raymond Sun Non-foreshortening intraluminal prosthesis
US7758627B2 (en) * 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
US7141062B1 (en) * 2000-03-01 2006-11-28 Medinol, Ltd. Longitudinally flexible stent
US8496699B2 (en) * 2000-03-01 2013-07-30 Medinol Ltd. Longitudinally flexible stent
US8202312B2 (en) * 2000-03-01 2012-06-19 Medinol Ltd. Longitudinally flexible stent
US8920487B1 (en) 2000-03-01 2014-12-30 Medinol Ltd. Longitudinally flexible stent
US8460367B2 (en) 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
EP1516600B1 (en) * 2001-09-18 2007-03-14 Abbott Laboratories Vascular Enterprises Limited Stent
US20030074051A1 (en) * 2001-10-16 2003-04-17 Kirsten Freislinger Luehrs Flexible stent
US7625398B2 (en) * 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
US20040054398A1 (en) * 2002-09-13 2004-03-18 Cully Edward H. Stent device with multiple helix construction
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7637942B2 (en) * 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US20030176914A1 (en) * 2003-01-21 2003-09-18 Rabkin Dmitry J. Multi-segment modular stent and methods for manufacturing stents
DE10342759A1 (en) * 2003-09-16 2005-04-14 Campus Gmbh & Co. Kg Stent with improved durability
US7887579B2 (en) * 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US20060190072A1 (en) * 2005-01-28 2006-08-24 Das Gladwin S Flexible cells for axially interconnecting stent components
US7731654B2 (en) * 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
GB0609841D0 (en) * 2006-05-17 2006-06-28 Angiomed Ag Bend-capable tubular prosthesis
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
CA2657138C (en) * 2006-07-10 2014-08-26 Mcneil-Ppc, Inc. Resilient device
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8047980B2 (en) * 2006-07-10 2011-11-01 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US8613698B2 (en) * 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
JP4852631B2 (en) * 2009-06-28 2012-01-11 株式会社沖データ Communication device and connection control method thereof
US20110152604A1 (en) * 2009-12-23 2011-06-23 Hull Jr Raymond J Intravaginal incontinence device
JP5847160B2 (en) * 2011-03-25 2016-01-20 テルモ株式会社 The stent and stent delivery system
BR112014028242A2 (en) 2012-05-14 2017-06-27 Bard Inc C R uniformly expandable stent
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US10271975B2 (en) 2013-03-15 2019-04-30 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
DE102014016588A1 (en) * 2014-11-11 2016-05-12 medicut Stent Technology GmbH stent graft
EP3307211A4 (en) * 2015-06-11 2018-07-25 Beijing Advanced Medical Technologies, Inc. A close-cell structured stent, a preparation method and use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356423A (en) 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US6461381B2 (en) 1994-03-17 2002-10-08 Medinol, Ltd. Flexible expandable stent
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
DE4418336A1 (en) 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
AT220308T (en) 1995-03-01 2002-07-15 Scimed Life Systems Inc Longitudinal Flexible and expandable stent
US5980553A (en) * 1996-12-20 1999-11-09 Cordis Corporation Axially flexible stent
US5695516A (en) * 1996-02-21 1997-12-09 Iso Stent, Inc. Longitudinally elongating balloon expandable stent
US5922021A (en) * 1996-04-26 1999-07-13 Jang; G. David Intravascular stent
US5776183A (en) * 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5868781A (en) 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US5810872A (en) 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5913895A (en) * 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
US5824059A (en) 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US6059822A (en) * 1997-08-22 2000-05-09 Uni-Cath Inc. Stent with different mesh patterns
US6042606A (en) 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
FR2768919B1 (en) * 1997-10-01 1999-11-19 Braun Celsa Sa expandable support for anatomical conduit
US6013091A (en) * 1997-10-09 2000-01-11 Scimed Life Systems, Inc. Stent configurations
EP1059896B1 (en) * 1998-03-04 2006-05-24 Boston Scientific Limited Improved stent cell configurations
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6132460A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent
US6132461A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
FR2777771B1 (en) * 1998-04-27 2000-08-25 Microval The stent and tubular flexible
US6730116B1 (en) * 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6245101B1 (en) 1999-05-03 2001-06-12 William J. Drasler Intravascular hinge stent
US20010047200A1 (en) * 1999-10-13 2001-11-29 Raymond Sun Non-foreshortening intraluminal prosthesis
US6398806B1 (en) 2000-12-26 2002-06-04 Scimed Life Systems, Inc. Monolayer modification to gold coated stents to reduce adsorption of protein

Cited By (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8092514B1 (en) * 1998-11-16 2012-01-10 Boston Scientific Scimed, Inc. Stretchable anti-buckling coiled-sheet stent
US20060122691A1 (en) * 1998-12-03 2006-06-08 Jacob Richter Hybrid stent
US9284637B2 (en) 1999-11-19 2016-03-15 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Implantable graft and methods of making same
US6820676B2 (en) 1999-11-19 2004-11-23 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US8641754B2 (en) * 2000-11-07 2014-02-04 Advanced Bio Prosthetic Surfaces, Ltd. a wholly owned subsidiary of Palmaz Scientific, Inc. Endoluminal stent, self-supporting endoluminal graft and methods of making same
US6679911B2 (en) * 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US20050182477A1 (en) * 2001-12-20 2005-08-18 White Geoffrey H. Intraluminal stent and graft
US20040093072A1 (en) * 2002-05-06 2004-05-13 Jeff Pappas Endoprosthesis for controlled contraction and expansion
US8075610B2 (en) 2002-05-06 2011-12-13 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
WO2003092549A3 (en) * 2002-05-06 2004-04-08 Abbott Lab Endoprosthesis for controlled contraction and expansion
WO2003092549A2 (en) * 2002-05-06 2003-11-13 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
US7637935B2 (en) 2002-05-06 2009-12-29 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
US20100063581A1 (en) * 2002-05-06 2010-03-11 Jeff Pappas Endoprosthesis For Controlled Contraction And Expansion
US7985249B2 (en) 2002-05-08 2011-07-26 Abbott Laboratories Corporation Endoprosthesis having foot extensions
US20140371839A1 (en) * 2002-07-19 2014-12-18 Covidien Lp Medical implant having a curlable matrix structure and method of use
US7704274B2 (en) 2002-09-26 2010-04-27 Advanced Bio Prothestic Surfaces, Ltd. Implantable graft and methods of making same
US7122049B2 (en) 2003-03-19 2006-10-17 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US7980289B2 (en) 2003-03-19 2011-07-19 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US8915954B2 (en) 2003-05-06 2014-12-23 Abbott Laboratories Endoprosthesis having foot extensions
US7625401B2 (en) 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
US8048146B2 (en) 2003-05-06 2011-11-01 Abbott Laboratories Endoprosthesis having foot extensions
US8109991B2 (en) 2003-05-06 2012-02-07 Abbot Laboratories Endoprosthesis having foot extensions
US9956320B2 (en) 2003-06-27 2018-05-01 Zuli Holdings Ltd. Amorphous metal alloy medical devices
US10213298B2 (en) 2004-03-11 2019-02-26 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US9974669B2 (en) 2005-11-10 2018-05-22 Edwards Lifesciences Cardiaq Llc Percutaneous heart valve
US9486336B2 (en) 2005-11-10 2016-11-08 Edwards Lifesciences Cardiaq Llc Prosthesis having a plurality of distal and proximal prongs
US9433514B2 (en) 2005-11-10 2016-09-06 Edwards Lifesciences Cardiaq Llc Method of securing a prosthesis
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US20090171426A1 (en) * 2007-12-28 2009-07-02 Cook Incorporated Radially expandable stent
US8470021B2 (en) 2007-12-28 2013-06-25 Cook Medical Technologies Llc Radially expandable stent
US8894702B2 (en) * 2008-09-29 2014-11-25 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US20130184813A1 (en) * 2008-09-29 2013-07-18 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US9339377B2 (en) * 2008-09-29 2016-05-17 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US20130131793A1 (en) * 2008-09-29 2013-05-23 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US20130131788A1 (en) * 2008-09-29 2013-05-23 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US9456896B2 (en) * 2008-09-29 2016-10-04 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US10149756B2 (en) 2008-09-29 2018-12-11 Edwards Lifesciences Cardiaq Llc Heart valve
US9597183B2 (en) 2008-10-01 2017-03-21 Edwards Lifesciences Cardiaq Llc Delivery system for vascular implant
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US9333073B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery method
US8795356B2 (en) 2009-04-15 2014-08-05 Cardiaq Valve Technologies, Inc. Vascular implant
US20140309731A1 (en) * 2009-04-15 2014-10-16 Cardiaq Valve Technologies, Inc. Vascular implant
US9339379B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339378B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339380B2 (en) * 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant
US20140172086A1 (en) * 2009-04-15 2014-06-19 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US9333074B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9585747B2 (en) * 2009-04-15 2017-03-07 Edwards Lifesciences Cardiaq Llc Vascular implant
US20110009941A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8795345B2 (en) 2009-07-08 2014-08-05 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US9072537B2 (en) 2009-07-08 2015-07-07 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US9044263B2 (en) 2009-07-08 2015-06-02 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110009875A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Embolic obstruction retrieval devices and methods
US8529596B2 (en) 2009-07-08 2013-09-10 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8357178B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110009940A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8357179B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8795317B2 (en) 2009-07-08 2014-08-05 Concentric Medical, Inc. Embolic obstruction retrieval devices and methods
US20110009950A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110184456A1 (en) * 2009-07-08 2011-07-28 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US9949827B2 (en) 2009-09-29 2018-04-24 Edwards Lifesciences Cardiaq Llc Replacement heart valves, delivery devices and methods
US10166097B2 (en) 2009-09-29 2019-01-01 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10314705B2 (en) 2012-05-30 2019-06-11 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10016275B2 (en) 2012-05-30 2018-07-10 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent

Also Published As

Publication number Publication date
US6881222B2 (en) 2005-04-19
CA2386335A1 (en) 2001-04-19
US8721705B2 (en) 2014-05-13
EP1233723A1 (en) 2002-08-28
EP1233723A4 (en) 2005-10-05
AU1199901A (en) 2001-04-23
CA2386335C (en) 2008-12-30
US20020065549A1 (en) 2002-05-30
AU779189B2 (en) 2005-01-13
WO2001026583A1 (en) 2001-04-19
US20050187610A1 (en) 2005-08-25
JP2003523792A (en) 2003-08-12

Similar Documents

Publication Publication Date Title
US6887264B2 (en) Expandable stent and method for delivery of same
CA2283728C (en) Helical mesh endoprosthesis and methods of use
CA2293469C (en) Enhanced flexibility surgical stent
EP0782415B1 (en) Permanent shape memory alloy stent
US6565600B2 (en) Articulated expandable intraluminal stent
US6423091B1 (en) Helical stent having flat ends
US6663664B1 (en) Self-expanding stent with time variable radial force
US6432132B1 (en) Expandable intraluminal endoprosthesis
US6773455B2 (en) Stent with reinforced struts and bimodal deployment
CA2515951C (en) Intravascular stent
EP0888093B2 (en) Expandable stent
US6551351B2 (en) Spiral wound stent
EP2231079B1 (en) Stent
US6682554B2 (en) Methods and apparatus for a stent having an expandable web structure
AU674352B2 (en) A radially self-expanding implantable intraluminal device
EP1954223B1 (en) Stent configurations
US7476245B2 (en) Polymeric stent patterns
US6709453B2 (en) Longitudinally flexible stent
US8025694B2 (en) Modular vascular prosthesis and methods of use
CA2303344C (en) Improved stent configurations
US6315791B1 (en) Self-expanding prothesis
EP2364676B1 (en) Endoprosthesis having foot extensions
US6027526A (en) Stent having varied amounts of structural strength along its length
EP1729681B1 (en) Partially biodegradable stent
EP1427352B1 (en) Stent with offset cell geometry

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHARMACIA & UPJOHN AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUO, PETER P.;ZHOU, STEPHEN Q.;LIAU, CHRISTINE J.Y.;AND OTHERS;REEL/FRAME:010422/0383;SIGNING DATES FROM 19991018 TO 19991020

AS Assignment

Owner name: ENDOSYSTEMS LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WHITE, GEOFFREY H.;REDMOND, RUSSELL J.;PLYLEY, ALAN K.;REEL/FRAME:010583/0181;SIGNING DATES FROM 19991027 TO 20000218

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION